NDC 62135-496
Griseofulvin MICROSIZE
Griseofulvin
Griseofulvin MICROSIZE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Chartwell Rx, Llc.. The primary component is Griseofulvin.
Product ID | 62135-496_e1015d4f-428a-4b66-b55b-aabc86d223d3 |
NDC | 62135-496 |
Product Type | Human Prescription Drug |
Proprietary Name | Griseofulvin MICROSIZE |
Generic Name | Griseofulvin |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1971-09-09 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA060569 |
Labeler Name | Chartwell RX, LLC. |
Substance Name | GRISEOFULVIN |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |